Zai Lab Ltd (ZLAB) stock

ZLABNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30504% above fair value

$26.04−0.38 (-1.44%)

Close on Nov 12, 2026Market cap $4.04BP/E –Yield –

Zai Lab statistics

85 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Feb 25, 2027 (estimated, before the open)
Last ex-dividend date: No dividends
Fundamentals through: Sep 30, 2026
Share price as of: Nov 12, 2026

Valuation ratiosIndustry

Market Cap: $4.04B; $280.48M
Enterprise Value: $3.74B; $148.62M
PS Ratio: 9.16; 3.60
PB Ratio: 7.18; 2.05
P/TBV Ratio: 8.46; 2.29

Enterprise valuationIndustry

EV / Sales: 8.46; 2.60

Share statisticsIndustry

Shares Outstanding: 1.55B; 58M
Shares Change (YoY): 3.53%; 10.9%
Shares Change (QoQ): 0.17%; 0.51%
Float: 1.54B; 49M
Shares Held by Insiders: 0.67%; 12.1%
Shares Held by Institutions: 2.79%; 56.4%

Short sellingIndustry

Short Interest: 8M; –
Short Interest Change: -8.49%; -0.76%
Days to Cover: 6.67; 5.13

Stock price statisticsIndustry

52-Week High: $29.02; –
52-Week Low: $15.96; –
20-Day Moving Average: $23.91; –
50-Day Moving Average: $24.66; –
200-Day Moving Average: $21.26; –
Average True Range (14): $1.44; –
Price Change (1 Week): 15.2%; 1.51%
Price Change (1 Month): 15.7%; -2.35%
Price Change (3 Months): 0.54%; -21.1%
Price Change (6 Months): 28.1%; -22.6%
Price Change (YTD): 47.6%; -22.6%
Price Change (1 Year): 18.4%; -20.7%
Price Change (3 Years): -3.70%; -27.4%
Price Change (5 Years): -69.4%; -77.3%
Average Volume (10 Days): 1M; –
Average Volume (20 Days): 1M; –
Average Volume (90 Days): 1M; –
Relative Volume: 0.84; 0.79
Relative Strength Index (14): 58.6; 44.7
Volatility (1 Year): 52.1%; 80.4%
Beta (5 Years): 1.11; 1.07

MarginsIndustry

Gross Margin: 54.7%; 53.0%
Operating Margin: -63.0%; -38.7%
Pretax Margin: -45.9%; -11.8%
Profit Margin: -44.9%; -32.0%
EBITDA Margin: -59.3%; -27.7%
FCF Margin: -37.0%; -9.20%

Returns on capitalIndustry

Return on Equity (ROE): -30.0%; -51.2%
Return on Assets (ROA): -18.2%; -40.6%
Return on Invested Capital (ROIC): -87.6%; -32.9%
Return on Capital Employed (ROCE): -46.4%; -38.0%

Financial positionIndustry

Current Ratio: 2.04; 3.30
Quick Ratio: 1.47; 2.42
Debt / Equity: 0.45; 0.49
Interest Coverage: -45.16; -6.35

GrowthIndustry

Revenue Growth (YoY): 0.02%; 7.01%
Revenue Growth (3Y CAGR): 28.9%; 2.25%
Revenue Growth (5Y CAGR): 56.5%; 6.41%

EfficiencyIndustry

Asset Turnover: 0.40; 0.40
Inventory Turnover: 2.63; 2.73
Revenue Per Employee: $247.61K; $429.29K
Profits Per Employee: -$111.20K; -$683.67K
Employee Count: 1,784; 75
WACC: 10.1%; 10.1%

Income statement (TTM)Industry

Revenue: $441.73M; $66.37M
Gross Profit: $241.64M; $116.10M
Operating Income: -$278.26M; -$20.99M
Pretax Income: -$202.77M; -$13.23M
Net Income: -$198.39M; -$21.61M
EBITDA: -$261.81M; -$16.85M
EPS (Diluted): -$0.19; -$0.75

Balance sheetIndustry

Cash & Short-Term Investments: $559.66M; $67.63M
Total Debt: $252.37M; $116.91M
Net Cash (Debt): $307.29M; $17.46M
Net Cash Per Share: $0.20; $0.72
Equity (Book Value): $563.28M; $53.27M
Book Value Per Share: $0.36; $1.50
Tangible Book Value: $477.98M; $26.82M
Working Capital: $440.15M; $79.47M

Cash flow (TTM)Industry

Operating Cash Flow: -$159.21M; -$12.27M
Capital Expenditures: -$4.13M; -$944.00K
Free Cash Flow: -$163.34M; -$18.20M
FCF Per Share: -$0.11; -$0.42

Dividends and yieldsIndustry

Earnings Yield: -4.91%; -20.8%
FCF Yield: -4.04%; -9.58%

Taxes and interestIndustry

Interest Expense: $6.16M; $2.93M
Income Tax: -$4.38M; $74.00K

Scores and fair valueIndustry

Altman Z-Score: 1.52; 0.30
Piotroski F-Score: 4; 4
Beneish M-Score: -2.36; -2.62

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

Period	ZLAB	S&P 500	Difference	ZLAB per year	S&P 500 per year
1 month	+5.9%	-2.7%	+8.6 pts
3 months	+2.2%	-1.7%	+3.9 pts
Year to date	+47.6%	+11.9%	+35.7 pts
1 year	+19.0%	+12.0%	+7.0 pts
3 years	-7.6%	+78.2%	−85.7 pts	-2.6%	+21.2%
5 years	-69.4%	+73.2%	−142.7 pts	-21.1%	+11.6%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

8M ZLAB shares were sold short on Oct 30, 2026, down 8.5% from the previous report. At recent volumes it would take 6.7 days to buy them back. Over the last 20 sessions, 48.3% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	8,092,682	-8.5%	1,213,439	6.7
Oct 15, 2026	8,843,854	+23.7%	783,731	11.3
Sep 30, 2026	7,149,727	-12.3%	791,166	9.0
Sep 15, 2026	8,156,879	+1.7%	888,062	9.2
Aug 31, 2026	8,017,185	+7.4%	1,093,028	7.3
Aug 14, 2026	7,465,887	+14.3%	1,395,794	5.3
Jul 31, 2026	6,534,451	+2.9%	602,393	10.8
Jul 15, 2026	6,351,893	-22.1%	848,087	7.5
Jun 30, 2026	8,154,038	+12.5%	1,023,356	8.0
Jun 15, 2026	7,250,668	+11.0%	1,093,348	6.6
May 29, 2026	6,532,695	+25.9%	769,502	8.5
May 15, 2026	5,187,168	+16.5%	766,967	6.8